Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125493522 | 12549352 | 2 | F | 201210 | 20160728 | 20160712 | 20160804 | EXP | DK-DKMA-ADR 23546582 | DK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44526DB | BOEHRINGER INGELHEIM | 43.33 | YR | F | Y | 80.00000 | KG | 20160804 | CN | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125493522 | 12549352 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125493522 | 12549352 | 1 | Renal artery thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125493522 | 12549352 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125493522 | 12549352 | Dyspnoea | |
| 125493522 | 12549352 | Fatigue | |
| 125493522 | 12549352 | Haemorrhagic anaemia | |
| 125493522 | 12549352 | Menorrhagia | |
| 125493522 | 12549352 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125493522 | 12549352 | 1 | 20121022 | 20141008 | 0 |